Avacta
Bristol Myers Squibb
F-Star Therapeutics
GlaxoSmithKline
Immutep
Innovent
Macrogenics
Merck
Nanobiotix
Novartis
Symphogen
Published | Pages | Publisher | Report code |
---|---|---|---|
Jan 2022 | 150 | Kuick Research | ASDR-595498 |
Avacta
Bristol Myers Squibb
F-Star Therapeutics
GlaxoSmithKline
Immutep
Innovent
Macrogenics
Merck
Nanobiotix
Novartis
Symphogen